- Home
- RRGB vs CTMX Comparison
RRGB vs CTMX Comparison
Compare RRGB & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRGB
- CTMX
- Stock Information
- Founded
- RRGB 1969
- CTMX 2008
- Country
- RRGB United States
- CTMX United States
- Employees
- RRGB N/A
- CTMX N/A
- Industry
- RRGB Restaurants
- CTMX Biotechnology: Pharmaceutical Preparations
- Sector
- RRGB Consumer Discretionary
- CTMX Health Care
- Exchange
- RRGB Nasdaq
- CTMX Nasdaq
- Market Cap
- RRGB 88.7M
- CTMX 444.3M
- IPO Year
- RRGB 2002
- CTMX 2015
- Fundamental
- Price
- RRGB $6.01
- CTMX $2.42
- Analyst Decision
- RRGB Strong Buy
- CTMX Strong Buy
- Analyst Count
- RRGB 4
- CTMX 2
- Target Price
- RRGB $11.88
- CTMX $5.00
- AVG Volume (30 Days)
- RRGB 374.7K
- CTMX 2.4M
- Earning Date
- RRGB 08-21-2025
- CTMX 08-07-2025
- Dividend Yield
- RRGB N/A
- CTMX N/A
- EPS Growth
- RRGB N/A
- CTMX 128.27
- EPS
- RRGB N/A
- CTMX 0.49
- Revenue
- RRGB $1,252,370,000.00
- CTMX $147,557,000.00
- Revenue This Year
- RRGB N/A
- CTMX N/A
- Revenue Next Year
- RRGB N/A
- CTMX N/A
- P/E Ratio
- RRGB N/A
- CTMX $5.36
- Revenue Growth
- RRGB N/A
- CTMX 23.81
- 52 Week Low
- RRGB $2.50
- CTMX $0.40
- 52 Week High
- RRGB $7.05
- CTMX $3.10
- Technical
- Relative Strength Index (RSI)
- RRGB 56.69
- CTMX 52.71
- Support Level
- RRGB $5.88
- CTMX $2.33
- Resistance Level
- RRGB $6.89
- CTMX $2.79
- Average True Range (ATR)
- RRGB 0.42
- CTMX 0.18
- MACD
- RRGB -0.05
- CTMX -0.01
- Stochastic Oscillator
- RRGB 61.14
- CTMX 46.38
About RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. The company has one operating and one reportable segment: restaurants.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.